GenAI

Digital

It’s no longer about what GenAI can do. It’s about what it should do – and whether it can consistently deliver value at scale.

Digital

Just a year ago, the GenAI buzz in pharma felt like the start of a gold rush. Leaders greenlit pilots. Teams spun up proof-of-concepts.

News

Novo Nordisk and tech giant NVIDIA have joined forces on a new project that aims to speed up drug discovery using generative AI.

News

The FDA has rolled out its highly-touted generative AI tool, almost a month early, with a promise to reduce the time taken for regulatory reviews.

News

An AI model is being piloted at a national scale for the first time, but will it be able to predict future health risks reliably?

Market Access

The Joint Clinical Assessment (JCA) framework took effect on 12th January 2025, and its impact is top of mind among pharma innovators today.